Remaining variola virus stock has been restricted to the WHO Collaborating Centers on Smallpox and other Poxvirus Infections at the CDC and the Russian State Research Centre of Virology and Biotechnology (SRC VB VECTOR) labs. After the events of Sept. 11, 20001 in the United States, the concern arose for the deliberate release of the virus as an act of bioterrorism, and research for medical countermeasures including vaccines and anti-viral medications was renewed.